Retrospective study on Attana’s track record published in IBI shows extraordinary results
Today, a retrospective study on Attana’s track record was published in IBI (International Biopharmaceutical Industry). The study evaluates the outcome of all the 77 drug candidates Attana has analyzed for customers in the pre-clinical phase.The result of the study shows Attana has had an accuracy of 100% in determining which candidates will succeed in clinical trials, outperforming the company’s previously communicated expectations. The findings suggest that Attana’s proprietary technology and validation process has improved clinical trial success rates by over 80%. If the accuracy of the